Company: IXHL
Filing Date: 2025-04-16
Form Type: S-1/A
Source: 0001213900-25-032577
Chunk: 52

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-16
Form: S-1/A
Chunk 52
---

entered into the March 2025 Purchase Agreements with the selling stockholders for the purchase and sale of 9,687,045 PIPE Shares for a
purchase price of $1.08 per share of Common Stock (and, in lieu thereof, Pre-Funded Warrants to purchase up to 1,887,045 Pre-Funded Warrant
Shares) at a price of $1.0799 per Pre-Funded Warrant and Series A Warrants to purchase up to 11,574,090 Series A Warrant Shares, subject
to adjustment as described therein at an initial exercise price of $2.16 per share.

The Series A Warrants are not currently exercisable and will be exercisable
following Stockholder Approval and expire two and one-half (2.5) years after the date of Stockholder Approval. The exercise price and
number of shares of Common Stock issuable upon exercise of the Series A Warrant are subject to adjustment to up to an aggregate of 347,222,700
shares of Common Stock as described therein. The exercise price and number of shares of Common Stock issuable upon exercise of the Series
A Warrant are subject to adjustment for recapitalizations and similar events and based on the trading price of the Common Stock for certain
periods following the Stockholder Approval, each as described in the Series A Warrant. Adjustment of the Series A Warrant exercise price
is currently subject to a floor price of $1.08 per share and will be adjusted to a floor price of $0.216 per share following receipt of
Stockholder Approval. Under the zero exercise price option, the holder of the Series A Warrant has the right to receive an aggregate number
of shares equal to the product of (x) the aggregate number of shares of common stock that would be issuable upon a cash exercise of the
Series A Warrant (which is subject to adjustment to a number of shares that is up to 10 times the number of shares underlying the Series
A Warrant at issuance) multiplied by (y) 3.0. The Pre-Funded Warrants are exercisable for shares of Common Stock for a nominal exercise
price of $0.0001 per Pre-Funded Warrant Share, are immediately exercisable upon issuance and expire when exercised in full.

The PIPE Shares, Pre-Funded
Warrants and Series A Warrants were offered and sold to the investors in reliance upon the exemption from registration provided by Section
4(a)(2)